Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 1
2008 1
2009 2
2011 1
2014 1
2015 1
2016 1
2017 1
2018 2
2019 3
2020 1
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent.
Cloux AJ, Aubry D, Heulot M, Widmann C, ElMokh O, Piacente F, Cea M, Nencioni A, Bellotti A, Bouzourène K, Pellegrin M, Mazzolai L, Duchosal MA, Nahimana A. Cloux AJ, et al. Among authors: bouzourene k. Oncotarget. 2019 Nov 19;10(62):6723-6738. doi: 10.18632/oncotarget.27336. eCollection 2019 Nov 19. Oncotarget. 2019. PMID: 31803365 Free PMC article.
Experimental Drainage Device to Reduce Lymphoedema in a Rat Model.
Triacca V, Pisano M, Lessert C, Petit B, Bouzourene K, Nahimana A, Vozenin MC, Stergiopulos N, Swartz MA, Mazzolai L. Triacca V, et al. Among authors: bouzourene k. Eur J Vasc Endovasc Surg. 2019 Jun;57(6):859-867. doi: 10.1016/j.ejvs.2018.04.014. Epub 2018 May 25. Eur J Vasc Endovasc Surg. 2019. PMID: 29804748 Free article.
Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions.
Pellegrin M, Szostak J, Bouzourène K, Aubert JF, Berthelot A, Nussberger J, Laurant P, Mazzolai L. Pellegrin M, et al. Among authors: bouzourene k. J Cardiovasc Pharmacol Ther. 2017 Mar;22(2):159-168. doi: 10.1177/1074248416652235. Epub 2016 Jul 8. J Cardiovasc Pharmacol Ther. 2017. PMID: 27246357
18 results